Free Trial

Ambu A/S (OTCMKTS:AMBBY) Sees Unusually-High Trading Volume - Here's Why

Ambu A/S logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Ambu A/S saw 500 shares trade during mid-day (down 29% from 708 the prior session); the stock last traded at $11.00, up from the previous close of $10.20.
  • The company carries a market cap of $2.58 billion with a P/E of 35.48, healthy liquidity (quick ratio 1.67, current ratio 2.86) and very low leverage (debt-to-equity 0.08).
  • In its most recent quarter Ambu reported EPS $0.07 on revenue of $242.85 million, with a net margin of 8.86% and return on equity of 9.15%.
  • MarketBeat previews top five stocks to own in May.

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report) saw strong trading volume on Friday . 500 shares traded hands during mid-day trading, a decline of 29% from the previous session's volume of 708 shares.The stock last traded at $11.00 and had previously closed at $10.20.

Ambu A/S Stock Performance

The firm has a market cap of $2.58 billion, a price-to-earnings ratio of 35.48 and a beta of 1.25. The company has a quick ratio of 1.67, a current ratio of 2.86 and a debt-to-equity ratio of 0.08. The company has a 50 day moving average of $11.49 and a 200 day moving average of $13.29.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.The firm had revenue of $242.85 million during the quarter.

Ambu A/S Company Profile

(Get Free Report)

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company's core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu's offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ambu A/S Right Now?

Before you consider Ambu A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambu A/S wasn't on the list.

While Ambu A/S currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines